- Did you mean
- clinical efficacité
Search results - 56 results
Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
with the rHVT- H5 vaccine protected against challenge with the “variant” 2008 HPAI H5N1 Egyptian strain. Health Topics: Cabine de bronzage Category: A1 FOS Classification: 3.02 Clinical medicine ...
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
peripheral blood mononuclear cell population (PBMC s). These cells, expected to be a more specific biological matrix than whole blood to reflect pharmacological efficacy, could be promising for TAC therapeutic ...
Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
Secondary Influenza A Virus, H5N1 Subtype Influenza in Birds Influenza Vaccines Mouth Vaccines, Inactivated Vaccines, Synthetic Virus Shedding Abstract: The efficacy of different vaccination schedules was ...
Efficacy of metaphylactic florfenicol therapy during natural outbreaks of bovine respiratory disease.
Infections Pasteurella multocida Respiratory Tract Infections Thiamphenicol Tylosin Abstract: The efficacy of an injectable formulation of florfenicol (300 mg/mL) as metaphylactic control of naturally ...
Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
Vaccines, Inactivated Vaccines, Synthetic Virus Shedding Abstract: The efficacy of an inactivated vaccine containing the Eurasian isolate A/chicken/Italy/22A/98 H5N9 (H5N9-It) was compared with that of the ...
Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge.
carried out to determine the cross-protective efficacy of a commercial inactivated vaccine containing a BVDV-1 strain. A group of five BVDV-free calves was vaccinated twice and a second group of five calves ...
Improved tuberculosis DNA vaccines by formulation in cationic lipids.
Finally, formulation in Vaxfectin increased the protective efficacy of the Ag85B DNA vaccine, as measured by reduced relative light unit counts and CFU counts in the spleen and lungs from mice challenged ...
Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.
Pregnancy Complications, Infectious Swine Treatment Outcome Vaccination Vaccines, Marker Viral Vaccines Viremia Virus Shedding Abstract: The efficacy of two marker vaccines against classical swine fever (CSF) ...
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.
DNA Abstract: OBJECTIVE: To determine the efficacy of Ag85A- DNA against challenge with a highly virulent human clinical isolate of Mycobacterium tuberculosis (CSU37) and to compare the potencies of two ...
Total quality management for clinical laboratories: a need or a new fashion?130
Brussels Clinical Clinical Competence concept concepts conditions consequences CONTACT Countries EN Europe European European countries external general health Humans im implementation Improvement institution ...